Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Prolia
Pharma
Amgen CEO critiques FDA push to reform biosimilars market
As officials discuss easing biosim regulatory standards, Amgen execs shared a word of caution—and also optimism about being able to adapt.
Kevin Dunleavy
Nov 5, 2025 8:31am
A closer look at pharma’s top patent losses in 2025
Mar 21, 2025 9:00am
The top 10 drugs losing US exclusivity in 2025
Mar 17, 2025 3:00am
Amgen fends off Celltrion's proposed Prolia biosim until June
Jan 28, 2025 11:46am
Amid buzz for Amgen's obesity drug, company sees revenue boost
May 3, 2024 9:05am
Sandoz wins FDA nods for first Prolia, Xgeva biosimilars
Mar 6, 2024 9:52am
